Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1214-39-7

Post Buying Request

1214-39-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1214-39-7 Usage

Chemical Properties

Colorless to off-white or yellow powder. Corrosive. Insoluble in water, slightly soluble in ethanol, stable in acid and alkali.

Uses

6-Benzylaminopurine is a plant growth regulator that belongs to the class of first generation synthetic cytokinin used in agriculture.6-Benzylaminopurine has been used:to induce sprouting in plant materials.in seed germination medium for culturing of seeds.to modify Murashige and Skoog (MS) media for shoot initiation.inhibitor of respiratory kinase in plants.6-Benzylaminopurine, benzyl adenine (BAP) is a synthetic cytokinin which together with auxins elicits plant growth and development responses. BAP is a widely use cytokinin supplement to plant growth media such as Murashige and Skoog medium, Gamborg’s medium, and Chu’s N6 medium.

Application

6-Benzylaminopurine solution has been used as a component in the Murashige & Skoog medium (MS) for culturing mandarin explants and plantlets of Dendrocalamus asper (Schultes f.). It has also been used as a supplement in Nitsch and Nitsch medium (NN) of grapevine explants.

Preparation

synthesis of 6-benzylaminopurine: To 5g hypoxanthine, add 20mL SOCl2, 0.25g DMAP, 10gBTC dissolved in 20mL SOCl2. Heat and add BTC/SOCl2 dropwise. Reflux (refrigerant cooling) to complete dissolution, steam out SOCl2 (containing phosgene, which is used for recovery), evaporated (drained), cooled to room temperature to obtain a milky yellow solid (6-chloropurine and DMAP.Hcl). Directly add 4g benzylamine and 25g triethylamine to it, heat to 70~80 ℃, or microwave heating, until the 6-chloropurine reaction is complete (TLC monitoring), add ethanol, the solid filtered out is washed with ethanol, and dried to obtain 7 g of product 6-benzylaminopurine with a brown color.Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells

Definition

ChEBI: 6-Benzylaminopurine is a member of the class of 6-aminopurines that is adenine in which one of the hydrogens of the amino group is replaced by a benzyl group. It has a role as a plant metabolite and a cytokinin. It derives from an adenine.

General Description

6-Benzylaminopurine is a plant growth regulator that belongs to the class of first generation synthetic cytokinin used in agriculture commodities.

Health Hazard

6-benzylaminopurine (6-BA) is widely used in agriculture and horticulture as plant growth regulator. Its excessive use may pose a potential risk to both environment and human health, which is causing great concern. Vapor is irritating when breathed at high concentrations. Contact with liquid causes irritation of skin and burning of eyes; Vapors cause a slight smarting of the eyes or respiratory system if present in high concentrations; If spilled on clothing and allowed to remain, may cause smarting and reddening of the skin.

Agricultural Uses

6-Benzylaminopurine is a plant growth promoter, is the first applied synthetic cytokinin, mainlyused as a broad- spectrum plant growth regulator. It can be used inagriculture, horticulture, for plants at different stages, from germination to harvest. It enhance the shape of apples and to increase the fruit set in pears. It increases the yield of pistachios and tomatoes. Not listed for use in EU countries. Registered for use in the U.S.

Trade name

ABG? 3034; ACCEL?; AGTROL?; 6-BA?; BA? (growth stimulant); CHRYSAL BVB?; EXILIS?; PERLAN?; PROMALIN?; SD? 4901; SQ? 4609

Safety Profile

Moderately toxic by ingestion andskin contact. Human mutation data reported. Whenheated to decomposition it emits toxic vapors of NOx.

Potential Exposure

A polyamine plant growth regulator used to lengthen and enhance the shape of apples and to increase the fruit set in pears. It increases the yield of pistachios and tomatoes. Not listed for use in the EU countries.

Shipping

UN3259 Amines, solid, corrosive, n.o.s, or Polyamines, solid, corrosive, n.o.s., Hazard class: 8; Labels: 8—Corrosive material, Technical Name Required.

Purification Methods

It is purified by recrystallisation from aqueous EtOH. It has at 207 and 270nm (H2O), 268 nm max (pH 6), 274nm (0.1 N HCl) and 275nm (0.1 N NaOH). [Daly J Org Chem 21 1553 1956, Bullock et al. J Am Chem Soc 78 3693 1956, Beilstein 26 III/IV 3575.]

Incompatibilities

May react with strong oxidizers such as chlorates, peroxides, nitrates, etc. May release heat on contact with water. Solid and corrosive amines are chemical bases. Neutralize acids to form salts plus water in exothermic reactions. May be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. May generate flammable gaseous hydrogen in combination with strong reducing agents, such as hydrides.

Waste Disposal

Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. All federal, state, and local environmental regulations must be observed.

Check Digit Verification of cas no

The CAS Registry Mumber 1214-39-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,1 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1214-39:
(6*1)+(5*2)+(4*1)+(3*4)+(2*3)+(1*9)=47
47 % 10 = 7
So 1214-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H11N5/c1-2-4-9(5-3-1)6-13-11-10-12(15-7-14-10)17-8-16-11/h1-5,7-8,10H,6H2,(H,13,14,15,16,17)

1214-39-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1088)  N6-Benzyladenine  >99.0%(HPLC)(T)

  • 1214-39-7

  • 5g

  • 690.00CNY

  • Detail
  • TCI America

  • (B1088)  N6-Benzyladenine  >99.0%(HPLC)(T)

  • 1214-39-7

  • 25g

  • 1,870.00CNY

  • Detail
  • Alfa Aesar

  • (A14678)  6-Benzyladenine, 99%   

  • 1214-39-7

  • 1g

  • 178.0CNY

  • Detail
  • Alfa Aesar

  • (A14678)  6-Benzyladenine, 99%   

  • 1214-39-7

  • 5g

  • 729.0CNY

  • Detail
  • Alfa Aesar

  • (A14678)  6-Benzyladenine, 99%   

  • 1214-39-7

  • 25g

  • 2903.0CNY

  • Detail
  • Sigma-Aldrich

  • (67619)  6-Benzylaminopurine  analytical standard

  • 1214-39-7

  • 67619-100MG

  • 1,354.86CNY

  • Detail
  • Aldrich

  • (13151)  6-Benzylaminopurine  ReagentPlus®, ≥99.0% (HPLC)

  • 1214-39-7

  • 13151-1G-F

  • 219.96CNY

  • Detail
  • Aldrich

  • (13151)  6-Benzylaminopurine  ReagentPlus®, ≥99.0% (HPLC)

  • 1214-39-7

  • 13151-5G-F

  • 809.64CNY

  • Detail
  • Aldrich

  • (13151)  6-Benzylaminopurine  ReagentPlus®, ≥99.0% (HPLC)

  • 1214-39-7

  • 13151-25G-F

  • 3,204.63CNY

  • Detail

1214-39-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name N-benzyladenine

1.2 Other means of identification

Product number -
Other names 1H-Purin-6-amine, N-(phenylmethyl)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1214-39-7 SDS

1214-39-7Synthetic route

6-chloropurine
87-42-3

6-chloropurine

benzylamine
100-46-9

benzylamine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
With triethylamine In ethanol for 5h; Reflux;96%
at 100℃; for 0.0833333h; microwave irradiation;95%
With indium(III) chloride In acetonitrile at 120℃; for 1h; Microwave irradiation; regioselective reaction;93%
N6-Benzyladenosine
4294-16-0

N6-Benzyladenosine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
With hydrogenchloride In water at 100℃; for 3h; Reagent/catalyst; Temperature;92%
phenylmagnesium bromide

phenylmagnesium bromide

Benzotriazol-1-ylmethyl-(9H-purin-6-yl)-amine
111098-24-9

Benzotriazol-1-ylmethyl-(9H-purin-6-yl)-amine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
In diethyl ether at 25℃; for 16h;80%
6-methylsulfonylpurine
19769-32-5

6-methylsulfonylpurine

benzylamine
100-46-9

benzylamine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
In butan-1-ol for 0.75h; Substitution;78.2%
7-benzyl-6-benzylamino-2-chloropurine

7-benzyl-6-benzylamino-2-chloropurine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
With potassium hydroxide; hydrogen; palladium on activated charcoal In ethanol under 760 Torr; for 15h; Hydrogenation;69%
Conditions
ConditionsYield
at 130℃; for 17h;55%
6-N-2',3',5'-tri-O-tetraacetyladenosine
7387-58-8, 80007-24-5

6-N-2',3',5'-tri-O-tetraacetyladenosine

A

6-benzyladenine
1214-39-7

6-benzyladenine

B

α-D-ribofuranosyl-1-phosphate
18646-11-2

α-D-ribofuranosyl-1-phosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / N,N-dimethyl-formamide / 20 h / 20 °C
2: methanol; ammonia / 48 h / 20 °C
3: potassium dihydrogenphosphate; Escherichia coli purine nucleoside phosphorylase / 37 °C / pH 7.5 / aq. buffer; Enzymatic reaction
View Scheme
N6-acetyl-2',3',5'-tri-O-acetyl-N6-benzyladenosine
1338578-76-9

N6-acetyl-2',3',5'-tri-O-acetyl-N6-benzyladenosine

A

6-benzyladenine
1214-39-7

6-benzyladenine

B

α-D-ribofuranosyl-1-phosphate
18646-11-2

α-D-ribofuranosyl-1-phosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: methanol; ammonia / 48 h / 20 °C
2: potassium dihydrogenphosphate; Escherichia coli purine nucleoside phosphorylase / 37 °C / pH 7.5 / aq. buffer; Enzymatic reaction
View Scheme
benzyl bromide
100-39-0

benzyl bromide

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / N,N-dimethyl-formamide / 20 h / 20 °C
2: methanol; ammonia / 48 h / 20 °C
3: potassium dihydrogenphosphate; Escherichia coli purine nucleoside phosphorylase / 37 °C / pH 7.5 / aq. buffer; Enzymatic reaction
View Scheme
N6-Benzyladenosine
4294-16-0

N6-Benzyladenosine

A

6-benzyladenine
1214-39-7

6-benzyladenine

B

α-D-ribofuranosyl-1-phosphate
18646-11-2

α-D-ribofuranosyl-1-phosphate

Conditions
ConditionsYield
With Escherichia coli purine nucleoside phosphorylase at 25℃; pH=7.5; Kinetics; aq. phosphate buffer; Enzymatic reaction;
With potassium dihydrogenphosphate; Escherichia coli purine nucleoside phosphorylase at 37℃; pH=7.5; Equilibrium constant; aq. buffer; Enzymatic reaction;
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: magnesium methanolate / methanol / 3 h / 55 °C
2: sodium tetrahydroborate / methanol / 20 °C
View Scheme
C12H9N5
709619-15-8

C12H9N5

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 20℃;
C16H15N5O2

C16H15N5O2

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
With propylamine In methanol at 20℃;
Allopurinol
68-94-0

Allopurinol

benzylamine
100-46-9

benzylamine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 75℃; for 4h; Temperature; Reagent/catalyst;18.2 g
Allopurinol
68-94-0

Allopurinol

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: bis(trichloromethyl) carbonate; dmap; thionyl chloride / Reflux; Green chemistry
2: triethylamine / ethanol / Reflux; Inert atmosphere
View Scheme
hypoxanthine
68-94-0

hypoxanthine

6-benzyladenine
1214-39-7

6-benzyladenine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trichlorophosphate; N,N-dimethyl-aniline / 760.05 Torr / Heating
2: water / 0.75 h / 100 °C / Green chemistry
View Scheme
2-acetoxyethyl acetoxymethyl ether
59278-00-1

2-acetoxyethyl acetoxymethyl ether

6-benzyladenine
1214-39-7

6-benzyladenine

9-<(2-acetoxyethoxy)methyl>-6-benzylaminopurine
173205-63-5

9-<(2-acetoxyethoxy)methyl>-6-benzylaminopurine

Conditions
ConditionsYield
With aluminum oxide; silica gel for 0.0666667h; microwave irradiation;95%
methyl vinyl ketone
78-94-4

methyl vinyl ketone

6-benzyladenine
1214-39-7

6-benzyladenine

1-(butan-3-one-1-yl)-6-benzylaminopurine

1-(butan-3-one-1-yl)-6-benzylaminopurine

Conditions
ConditionsYield
With 1-methyl-1H-imidazole In dimethyl sulfoxide at 70℃; for 2h; Michael addition;94%
1-Bromo-2-chloroethane
107-04-0

1-Bromo-2-chloroethane

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-(2-chloroethyl)purine
120593-22-8

6-benzylamino-9-(2-chloroethyl)purine

Conditions
ConditionsYield
With sodium hydroxide; (C8H17)4NBr In water; benzene at 80℃; for 0.5h; Product distribution; other catalyst, other solvent, other reaction time, other temperature;90%
With sodium hydroxide; (C8H17)4NBr In water; benzene at 80℃; for 0.5h;90%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 16h;82%
acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

6-benzyladenine
1214-39-7

6-benzyladenine

3-(6-benzylamino-purin-9-yl)-propionic acid methyl ester

3-(6-benzylamino-purin-9-yl)-propionic acid methyl ester

Conditions
ConditionsYield
With 1-butyl-3-methylimidazolium hydroxide at 25℃; for 2h; Michael addition;90%
With 1-methyl-1H-imidazole In dimethyl sulfoxide at 70℃; for 2h; Michael addition;84%
acrylic acid n-butyl ester
141-32-2

acrylic acid n-butyl ester

6-benzyladenine
1214-39-7

6-benzyladenine

3-(6-benzylamino-purin-9-yl)-propionic acid butyl ester
1033400-03-1

3-(6-benzylamino-purin-9-yl)-propionic acid butyl ester

Conditions
ConditionsYield
With tetrabutylammomium bromide; zinc(II) oxide at 120℃; for 0.333333h; Michael addition; microwave irradiation;89%
1,3-chlorobromopropane
109-70-6

1,3-chlorobromopropane

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-(3-chloropropyl)purine
120593-24-0

6-benzylamino-9-(3-chloropropyl)purine

Conditions
ConditionsYield
With sodium hydroxide; (C8H17)4NBr In water; benzene at 80℃; for 1h;85%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

6-benzyladenine
1214-39-7

6-benzyladenine

N6-benzyl-9-(ethoxycarbonylmethyl)adenine

N6-benzyl-9-(ethoxycarbonylmethyl)adenine

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile for 0.0833333h; microwave irradiation;85%
ethylene dibromide
106-93-4

ethylene dibromide

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-(2-bromoethyl)purine
120593-27-3

6-benzylamino-9-(2-bromoethyl)purine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 16h;82%
With sodium hydroxide; tetrabutylammomium bromide In dichloromethane; water at 40℃; for 1h; Product distribution; other reaction time, other temperature;50%
With sodium hydroxide; tetrabutylammomium bromide In dichloromethane; water at 40℃; for 1h;50%
1-Bromo-2-chloroethane
107-04-0

1-Bromo-2-chloroethane

6-benzyladenine
1214-39-7

6-benzyladenine

Benzyl-(9-vinyl-9H-purin-6-yl)-amine
120593-26-2

Benzyl-(9-vinyl-9H-purin-6-yl)-amine

Conditions
ConditionsYield
With sodium hydroxide; (C8H17)4NBr In water; benzene at 80℃; for 2.5h; Product distribution; other catalyst, other solvent, other reaction time, other temperature;80%
With sodium hydroxide; (C8H17)4NBr In water; benzene at 80℃; for 2.5h;80%
6-benzyladenine
1214-39-7

6-benzyladenine

Bromoacetaldehyde diethyl acetal
2032-35-1

Bromoacetaldehyde diethyl acetal

N-benzyl-9-(2,2-diethoxyethyl)-9H-purin-6-amine
1527480-25-6

N-benzyl-9-(2,2-diethoxyethyl)-9H-purin-6-amine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 8h; Inert atmosphere;80%
methyl chloroacetate
96-34-4

methyl chloroacetate

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-((methoxycarbonyl)methyl)-9H-purine

6-benzylamino-9-((methoxycarbonyl)methyl)-9H-purine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 160℃; for 0.133333h; microwave irradiation;78%
vinyl acetate
108-05-4

vinyl acetate

6-benzyladenine
1214-39-7

6-benzyladenine

1-(6-benzylaminoallopurin-9-yl)ethyl acetate

1-(6-benzylaminoallopurin-9-yl)ethyl acetate

Conditions
ConditionsYield
With D-aminoacylase from Escherichia coli (EC 3.5.1.81) In dimethyl sulfoxide at 50℃; for 96h;77%
With [bmIm]OH at 50℃; for 24h; Markovnikov addition;70%
n-propyl chloracetate
5396-24-7

n-propyl chloracetate

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-((n-propoxycarbonyl)methyl)-9H-purine

6-benzylamino-9-((n-propoxycarbonyl)methyl)-9H-purine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 160℃; for 0.133333h; microwave irradiation;76%
4-(4-fluorophenyl)-4-oxo-n-butyl chloride
3874-54-2

4-(4-fluorophenyl)-4-oxo-n-butyl chloride

6-benzyladenine
1214-39-7

6-benzyladenine

cyclopropyl-{4-(6-(benzylamino)-9H-purin-9-yl)phenyl}methanone

cyclopropyl-{4-(6-(benzylamino)-9H-purin-9-yl)phenyl}methanone

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 140℃;76%
6-benzyladenine
1214-39-7

6-benzyladenine

isopropyl bromide
75-26-3

isopropyl bromide

6-benzylamino-9-isopropylpurine
111853-20-4

6-benzylamino-9-isopropylpurine

Conditions
ConditionsYield
With sodium hydroxide; (C8H17)4NBr In benzene for 3h; Heating;75%
With potassium carbonate In dimethyl sulfoxide Alkylation;
methyl 1,2,3-tri-O-acetyl-β-D-ribofuronate
68673-84-7

methyl 1,2,3-tri-O-acetyl-β-D-ribofuronate

6-benzyladenine
1214-39-7

6-benzyladenine

methyl 1-[N6-(benzyl)adenin-9-yl]-2,3-di-O-acetyl-β-D-ribofuronate
1012864-67-3

methyl 1-[N6-(benzyl)adenin-9-yl]-2,3-di-O-acetyl-β-D-ribofuronate

Conditions
ConditionsYield
Stage #1: 6-benzyladenine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 16h; Heating;
Stage #2: methyl 1,2,3-tri-O-acetyl-β-D-ribofuronate With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at 90℃; for 0.333333h; microwave irradiation; Further stages.;
75%
copper (II) carbonate hydroxide

copper (II) carbonate hydroxide

(carboxymethyl(4-methylbenzyl)amino)acetic acid
166826-77-3

(carboxymethyl(4-methylbenzyl)amino)acetic acid

water
7732-18-5

water

6-benzyladenine
1214-39-7

6-benzyladenine

[Cu(MEBIDA)(HBAP)(H2O)]·H2O

[Cu(MEBIDA)(HBAP)(H2O)]·H2O

Conditions
ConditionsYield
In isopropyl alcohol at 25 - 50℃; for 1h;75%
acrylonitrile
107-13-1

acrylonitrile

6-benzyladenine
1214-39-7

6-benzyladenine

3-(6-benzylamino-purin-9-yl)-propionitrile

3-(6-benzylamino-purin-9-yl)-propionitrile

Conditions
ConditionsYield
With triethylamine In water at 100℃; for 0.0833333h; Michael addition; microwave irradiation;74%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

6-benzyladenine
1214-39-7

6-benzyladenine

6-benzylamino-9-(2-tetrahydropyranyl)purine
2312-73-4

6-benzylamino-9-(2-tetrahydropyranyl)purine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In various solvent(s) for 2h; Addition; Heating;71.4%
2-ethoxy-ethanol
110-80-5

2-ethoxy-ethanol

6-benzyladenine
1214-39-7

6-benzyladenine

benzyl-[9-(2-ethoxy-ethyl)-9H-purin-6-yl]-amine
1013022-32-6

benzyl-[9-(2-ethoxy-ethyl)-9H-purin-6-yl]-amine

Conditions
ConditionsYield
With iodine; potassium carbonate; triethylamine; triphenylphosphine In N,N-dimethyl-formamide for 9h; Reflux;71%
With potassium carbonate; 1-n-butyl-3-methylimidazolim bromide; triethylamine; p-toluenesulfonyl chloride at 80℃; for 7h; Green chemistry; regioselective reaction;64%
With potassium carbonate; triethylamine In N,N-dimethyl-formamide for 4h; Heating;58%
With tetrachloromethane; tetra-(n-butyl)ammonium iodide; potassium carbonate; triphenylphosphine In N,N-dimethyl-formamide for 5h; Reflux;58%
copper (II) carbonate hydroxide

copper (II) carbonate hydroxide

2,2'-((furan-2-ylmethyl)azanediyl)diacetic acid
57362-11-5

2,2'-((furan-2-ylmethyl)azanediyl)diacetic acid

6-benzyladenine
1214-39-7

6-benzyladenine

[Cu(FurIDA)(HBAP)]

[Cu(FurIDA)(HBAP)]

Conditions
ConditionsYield
In methanol; water at 25℃; for 0.5h;70%
O,O‐diethyl 2-iodoethoxymethylphosphonate

O,O‐diethyl 2-iodoethoxymethylphosphonate

6-benzyladenine
1214-39-7

6-benzyladenine

A

O,O-diethyl((2-(6-(benzylamino)-7H-purin-7-yl)ethoxy)methyl)phosphonate

O,O-diethyl((2-(6-(benzylamino)-7H-purin-7-yl)ethoxy)methyl)phosphonate

B

O,O-diethyl((2-(6-(benzylamino)-9H-purin-9-yl)ethoxy)methyl)phosphonate

O,O-diethyl((2-(6-(benzylamino)-9H-purin-9-yl)ethoxy)methyl)phosphonate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 24h; regioselective reaction;A 3%
B 70%

1214-39-7Related news

The metabolism of Benzyladenine (cas 1214-39-7) by excised organs of Phaseolus vulgaris07/29/2019

Benzyladenine was more extensively metabolized by bean (Phaseolus vulgaris L.) roots than by bean stems and leaves. However, most of the benzyladenine absorbed by these two aerial organs was converted to a compound tentatively identified as ribosylbenzyladenine. Compared to other plant systems, ...detailed

Increase in final fruit size of tangor (Citrus reticulata × C. sinensis) cv W. Murcott by application of Benzyladenine (cas 1214-39-7) to flowers07/25/2019

Fruit development involves the phenomena of cell division and cell elongation. The process is signalled and regulated by the combined action of hormonal substances such as gibberellins, cytokinins and auxins. Benzyladenine (BA) in the presence of adequate internal auxin concentrations is able to...detailed

Investigation on the effect of Benzyladenine (cas 1214-39-7) on the germination, radicle growth and meristematic cells of Nigella sativa L. and Allium cepa L.07/24/2019

The effect of different benzyladenine (BA) treatments which is a phyto-regulator or plant hormone on the cytology and growth of Nigella sativa L. (Black seed) and Allium cepa L. (onion) were investigated. Six concentrations of benzyladenine ranging from 5 to 55 ppm were applied for 6, 12, 18, 24...detailed

Response of Fennel (Foeniculum vulgare, Mill) plants to foliar application of moringa leaf extract and Benzyladenine (cas 1214-39-7) (BA)07/21/2019

The aim of this study was to investigate the influence of foliar application of Moringa oleifera leaf extracts (control, 2.5% and 5% aqueous MLE, 2.5% and 5% ethanolic MLE) and/or benzyladenine (control, 50, 100 and 200 ppm BA) on the growth, fruit and oil yield and its main components and chemi...detailed

1214-39-7Relevant articles and documents

Design and synthesis of purine analogues as highly specific ligands for FcyB, a ubiquitous fungal nucleobase transporter

Lougiakis, Nikolaos,Gavriil, Efthymios-Spyridon,Kairis, Markelos,Sioupouli, Georgia,Lambrinidis, George,Benaki, Dimitra,Krypotou, Emilia,Mikros, Emmanuel,Marakos, Panagiotis,Pouli, Nicole,Diallinas, George

, p. 5941 - 5952 (2016)

In the course of our study on fungal purine transporters, a number of new 3-deazapurine analogues have been rationally designed, based on the interaction of purine substrates with the Aspergillus nidulans FcyB carrier, and synthesized following an effective synthetic procedure. Certain derivatives have been found to specifically inhibit FcyB-mediated [3H]-adenine uptake. Molecular simulations have been performed, suggesting that all active compounds interact with FcyB through the formation of hydrogen bonds with Asn163, while the insertion of hydrophobic fragments at position 9 and N6 of 3-deazaadenine enhanced the inhibition.

N6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro

Castiglioni, Sara,Romeo, Valentina,Casati, Silvana,Ottria, Roberta,Perrotta, Cristiana,Ciuffreda, Pierangela,Maier, Jeanette A. M.

, p. 533 - 545 (2018)

N6-isopentenyladenosine is an anti-proliferative and pro-apoptotic atypical nucleoside for normal and tumor cells. Considering the role of angiogenesis in various diseases, we investigated the cytotoxic effect of N6-isopentenyladenosine on human microvascular endothelial cells, protagonists in angiogenesis. Our results show that N6-isopentenyladenosine induced a significant reduction of cell viability, upregulated p21 and promoted caspase-3 cleavage in a dose dependent manner leading to apoptotic cell death as detected by FACS analysis. To understand structure-function relationship of N6-isopentenyladenosine, we investigated the effect of some N6-isopentenyladenosine analogs. Our results suggest that N6-isopentenyladenosine and some of its derivatives are potentially novel angiostatic agents and might be associated with other anti-angiogenic compounds for a better outcome.

Mechanism of formation of N2-benzylguanine in the reaction of 2-amino- 6-chloropurine with sodium benzyl oxide, and benzylation of nucleic acid bases

Koyama, Ken-Ichi,Hitomi, Kenichi,Terashima, Isamu,Kohda, Kohfuku

, p. 1395 - 1399 (1996)

The mechanism of formation of N2-benzylguanine in the reaction of 2- amino-6-chloropurine with a large excess (12-13 molar eq) of sodium benzyl oxide in benzyl alcohol at 130°C was studied. N2,O6-Dibenzylguanine, a reaction intermediate, was isolated and a possible mechanism for its formation is discussed. Furthermore, using this sodium benzyl oxide system, benzylation at the amino group of nucleic acid bases was facilitated.

Reactions of Adenine and Its N-Exo Substituted Analogues with Phenyl Glycidyl Ether

Neporozhneva,Studentzsov,Ramsh

, p. 2248 - 2254 (2021/02/12)

Abstract: The features of reactions of adenine with phenyl glycidyl ether depending on the solvent nature were studied. In DMF in the presence of K2CO3, an N9-alkyl derivative, an experimental antiviral drug 9-(2-hydroxy-3-phenoxypropyl)adenine, was formed predominantly. During alkylation in acetic acid, besides N9-, N3-, and N7-alkylation products were also isolated. Alkylation of 6-[alkyl(dialkyl)amino]purines with phenyl glycidyl ether in DMF produced N-exo substituted 9-(2-hydroxy-3-phenoxypropyl)adenine analogues.

Chemoenzymatic synthesis of cytokinins from nucleosides: Ribose as a blocking group

Oslovsky, Vladimir E.,Solyev, Pavel N.,Polyakov, Konstantin M.,Alexeev, Cyril S.,Mikhailov, Sergey N.

, p. 2156 - 2163 (2018/03/26)

Nucleoside phosphorylases are involved in the salvage pathways of nucleoside biosynthesis and catalyze the reversible reaction of a nucleobase with α-d-ribose-1-phosphate to yield a corresponding nucleoside and an inorganic phosphate. The equilibrium of these reactions is shifted towards nucleosides, especially in the case of purines. Purine nucleoside phosphorylase (PNP, EC 2.4.2.1) is widely used in labs and industry for the synthesis of nucleosides of practical importance. Bacterial PNPs have relatively broad substrate specificity utilizing a wide range of purines with different substituents to form the corresponding nucleosides. To shift the reaction in the opposite direction we have used arsenolysis instead of phosphorolysis. This reaction is irreversible due to the hydrolysis of the resulting α-d-ribose-1-arsenate. As a result, heterocyclic bases are formed in quantitative yields and can be easily isolated. We have developed a novel method for the preparation of cytokinins based on the enzymatic cleavage of the N-glycosidic bond of N6-substituted adenosines in the presence of PNP and Na2HAsO4. According to the HPLC analysis the conversion proceeds in quantitative yields. In the proposed strategy the ribose residue acts as a protective group. No contamination of the final products with AsO43- has been detected via HPLC-HRMS; simple analytical arsenate detection via ESI-MS has been proposed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1214-39-7